News / Announcements
Efficacy and Safety of Secukinumab in Juvenile Idiopathic Arthritis: Interim Results From the Extension of the JUNIPERA Trial
N Ruperto, I Foeldvari, E Alexeeva, NA Ayaz, G Schulert, S Ozen, A Popov, A Ramanan, C Scott, B Sozeri, E Zholobova, S Chakraborty, X Zhu, R Martin, S Whelan, S Kaur, L Pricop, DJ Lovell, A Martini, HI Brunner
Encore to EULAR and DGRh 2023
Submission Number: 1561594
Session: Poster Session A, Pediatric Rheumatology – Clinical Poster I: JIA
Date: Sunday November 12, 2023
Presentation Time: 9:00 AM – 11:00 AM
Open-Label Phase 3 Study of Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Pharmacokinetics, Effectiveness, Safety, and Immunogenicity over 252 Weeks
Nicola Ruperto, Daniel J. Lovell, Sarah Ringold, Xie L. Xu, Jocelyn H. Leu, Edwin Lam, Yuhua Wang, Alberto Martini, Hermine I. Brunner.
Session: Poster Session A(0345–0379) Pediatric Rheumatology – Clinical Poster I: JIA
Date: Sunday, November 12, 2023
Presentation time: 9:00 AM – 11:00 AM
Pharmacokinetic, Pharmacodynamic, and Safety Profile of Subcutaneous Belimumab in Pediatric Patients With SLE: Analysis of Data From a Multicenter, Open-Label Trial
Hermine I. Brunner, MD, MSc, MBA, Diego Oscar Viola, MD, Richard Dimelow, PhD, Inmaculada Calvo Penadés, MD, Christel Wilkinson, MSc, Juan Cruz Rizo Rodriguez, MD, Alina Lucica Boteanu, MD, Sylvia Kamphuis, MD, PhD, Kirsten Minden, MD, Gerd Horneff, MD, Jordi Anton, MD, PhD, Masaaki Mori, MD, PhD, Yuichi Yamasaki, MD, PhD, Jose Miyar Olaiz, MD, Rebecca Marino, PharmD, Andre van Maurik, PhD, Mohamed Okily, MD, MSc, PhD, Emad Yanni, MD, Paul Wilde, MSc
Submission Number: 1550088
Session: Poster Session B, Pediatric Rheumatology – Clinical Poster II: Connective Tissue Disease
Date: Monday November 13, 2023
Presentation Time: 9:00 AM – 11:00 AM